<DOC>
	<DOCNO>NCT00708344</DOCNO>
	<brief_summary>To compare antihypertensive efficacy combination irbesartan/hydrochlorothiazide ( HCTZ ) use either usual active elective titration regimen . The main efficacy criterion change mean Systolic Blood Pressure ( SBP ) , measure doctor 's office automatic device , 10-week treatment period hypertensive patient insufficiently control monotherapy .</brief_summary>
	<brief_title>ACTUAL : Efficacy Safety Irbesartan/Hydrochlorothiazide Combination</brief_title>
	<detailed_description />
	<mesh_term>Irbesartan</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>Established essential hypertension treat least 4 week one antihypertensive drug alone With uncontrolled Blood Pressure ( BP ) define : SBP ≥ 160 mmHg and/or DBP ≥ 100 mmHg non diabetic patient SBP ≥ 150 mmHg and/or DBP ≥ 90 mmHg diabetic patient SBP ≥ 180 mmHg and/or DBP ≥ 110 mmHg V1 Known suspect cause secondary hypertension Patient bilateral renal artery stenosis , renal artery stenosis solitary kidney ; history renal transplant one functioning kidney Associated cardiovascular condition prevent patient stop current antihypertensive drug ( e.g . : Betablocker angina , ACEinhibitors heart failure , etc… ) . Known hypersensitivity diuretic sulphonamides history angioedema cough relate administration angiotensin II receptor antagonist combination drug use Known contraindication study drug : Severe renal dysfunction ( creatinine clearance &lt; 30ml/min ) Known hypokaliemia ( &lt; 3 mmol/L ) , know hypercalcemia Severe hepatic impairment , biliary cirrhosis , cholestasis Inability obtain valid automatic BP measurement record Administration investigational drug within 30 day prior study entry course study Presence severe medical psychological condition , opinion investigator , indicate participation study best interest subject . Presence condition ( e.g . geographic , social , etc ) would restrict limit subject participation duration study . Pregnant breastfeed woman Women childbearing potential protected effective contraceptive method birth control The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>